Walleye Trading
HAE icon

Walleye Trading’s Haemonetics HAE Stock Holding History

Walleye Trading’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-71,200
Closed -$5.71M – 4356
2025
Q4 		$5.71M Sell
71,200
-6,800
-9% -$457K 0.01% 1213
2025
Q3 		$3.8M Buy
78,000
+12,000
+18% +$743K 0.01% 1401
2025
Q2 		$4.92M Sell
66,000
-8,200
-11% -$543K 0.01% 1219
2025
Q1 		$4.72M Sell
74,200
-900
-1% -$61.2K 0.01% 1133
2024
Q4 		$5.86M Buy
75,100
+9,100
+14% +$731K 0.01% 1055
2024
Q3 		$5.31M Hold
66,000
– – 0.01% 1105
2024
Q2 		$5.46M Buy
+66,000
New +$5.81M 0.01% 1019
2022
Q1 		– Sell
-2,400
Closed -$127K – 5532
2021
Q4 		$127K Sell
2,400
-18,200
-88% -$1.11M ﹤0.01% 4250
2021
Q3 		$1.45M Buy
+20,600
New +$1.3M 0.01% 1866

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Trading's HAE Position: Q1 2026 in Review

Walleye Trading sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 6,822 shares — an estimated $547K sold.

Walleye Trading first reported a position in HAE in Q2 2015 and held it in 13 quarters. The position peaked at $722K in Q2 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Walleye Trading reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 6,822 Haemonetics shares in Q1 2026, an estimated $547K.
  • Walleye Trading first reported a position in Haemonetics in Q2 2015 and held it in 13 quarters.
  • Walleye Trading's Haemonetics position peaked at $722K in Q2 2022.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.